Adarsh Kumar Chiranjivi
Affiliations: | 2014- | Biosciences and Bioengineering | Indian Institute of Technology Guwahati |
Google:
"Adarsh Chiranjivi"Mean distance: (not calculated yet)
Parents
Sign in to add mentorVikash Dubey | grad student | 2014- | Indian Institute of Technology Guwahati |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gupta MK, Chiranjivi AK, Dutta T, et al. (2022) Synthesis and characterization of zinc derivatized 3, 5-dihydroxy 4', 7-dimethoxyflavone and its anti leishmaniasis activity against Leishmania donovani. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine |
Saha G, Chiranjivi AK, Khamar BM, et al. (2020) BLIMP-1 Mediated Downregulation of TAK1 and p53 Molecules Is Crucial in the Pathogenesis of . Frontiers in Cellular and Infection Microbiology. 10: 594431 |
Chiranjivi AK, Prakash J, Saha G, et al. (2020) Mutational studies on Leishmania donovani dihydrolipoamide dehydrogenase (LdBPK291950.1) indicates that the enzyme may not be classical class-I pyridine nucleotide-disulfide oxidoreductase. International Journal of Biological Macromolecules |
Prakash J, Yadav S, Saha G, et al. (2018) Episomal expression of human glutathione reductase (HuGR) in Leishmania sheds light on evolutionary pressure for unique redox metabolism pathway: Impaired stress tolerance ability of Leishmania donovani. International Journal of Biological Macromolecules |
Baranwal A, Chiranjivi AK, Kumar A, et al. (2018) Design of commercially comparable nanotherapeutic agent against human disease-causing parasite, Leishmania. Scientific Reports. 8: 8814 |
Chiranjivi AK, Dubey VK. (2018) Dihydrolipoamide dehydrogenase from Leishmania donovani: New insights through biochemical characterization. International Journal of Biological Macromolecules |
Bhalla P, Sultana S, Chiranjivi AK, et al. (2017) Synthesis of Methyl 4-(7-hydroxy-4,4,8-trimethyl-3-oxabicyclo[3.3.1]nonan-2-yl)benzoate and their evaluation as anti-leishmanial: Synergistic effect with Miltefosine. Antimicrobial Agents and Chemotherapy |
Bhardwaj R, Das M, Singh S, et al. (2017) Evaluation of CAAX prenyl protease II of Leishmania donovani as potential drug target: Infectivity and growth of the parasite is significantly lowered after the gene knockout. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences |